Smaller, faster, greener eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
AI can help reduce risk of HIV in high-risk communities
How to get good information to the people who need it is a question that has long plagued public health officials.
One approach, known as peer change agents, is to recruit peer leaders to promote healthy behaviors and information about disease prevention within their social networks. This strategy has been used, with mixed results, in communities at high risk for HIV infection and transmission, specifically among young people experiencing homelessness.
Youth experiencing homelessness are 10 times more likely to test positive for HIV than young people who have access to stable housing. Social workers and public health officials have used the peer change agents strategy to promote behaviors such as condom usage and regular HIV testing within these communities, but success seems tied to choosing the right peer leaders who will have the largest impact within their communities.
New diagnostic platform can rapidly measure COVID-19-related biomarkers
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
The research collaboration further cements both parties commitment to bringing the Wyss multiplexed electrochemical detection system forward as a diagnostic tool during the pandemic and follows a licensing agreement coordinated by Harvard s Office of Technology Development (OTD) in November 2020 that granted The iQ Group Global non-exclusive, term-limited access to the eRapid technology in accordance with the Univer
Emulate Names Donald Ingber to Board of Directors
Technology Visionary will Offer Strategic Insight to Guide Ongoing Research & Development of Market Leading Organ-on-a-Chip Technology
News provided by
Share this article
Share this article
BOSTON, Feb. 18, 2021 /PRNewswire/ Emulate, Inc., a leading provider of organ-on-a-chip technology today announced the appointment of Donald Ingber, M.D., Ph.D., to its Board of Directors. Ingber, the scientific founder of Emulate and Chairman of its Scientific Advisory Board is a pioneer in the field of biologically inspired engineering. His work has led to major advances in mechanobiology, tumor angiogenesis, tissue engineering, systems biology, nanobiotechnology and translational medicine.